Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
LaunchGlenmark Pharmaceuticals Inc., USA launches Micafungin for Injection USP in 50 mg and 100 mg vials to expand its institutional product offerings.
Glenmark Pharmaceuticals Inc., USA has announced the launch of Micafungin for Injection USP, available in 50 mg and 100 mg single-dose vials, set to begin distribution in September 2025.
Company Information
Company
Glenmark Pharmaceuticals
Location
B D Sawant Marg
Mumbai, Maharashtra, India
About
Glenmark Pharmaceuticals is a pharmaceutical company headquartered in Mumbai, India. The company focuses on the discovery, development, manufacturing, and marketing of a wide range of pharmaceutical products, including branded and generic formulations, biologics, and active pharmaceutical ingredients (APIs).
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Glenmark Pharmaceuticals ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.